An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
ORPEA Terminates Its Existing Liquidity Contract With Gilbert Dupont, Enters Into a New Liquidity Contract With Natixis-ODDO BHF And Suspends the Liquidity Contract
ORPEA Terminates Its Existing Liquidity Contract With Gilbert Dupont, Enters Into a New Liquidity Contract With Natixis-ODDO BHF And Suspends the Liquidity Contract
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Negative)
Tags
Rhea-AI Summary
ORPEA has announced the termination of its liquidity contract with Gilbert Dupont, which has been in effect since August 4, 2005. As of today, ORPEA holds 68,030 shares and €415,000 in the liquidity account. A new liquidity contract is set to begin on December 1, 2022 with NATIXIS-ODDO BHF, aiming to enhance trading for ORPEA shares. The contract will be suspended until the company's restructuring process is completed. ORPEA continues to operate across 22 countries, focusing on elderly care and rehabilitation.
Positive
Entering a new liquidity contract with NATIXIS-ODDO BHF aims to enhance share trading.
ORPEA continues to have substantial resources allocated to its liquidity account.
Company operates in 22 countries, indicating a broad market presence.
Negative
Liquidity contract operations are suspended until after the restructuring process.
Termination of the liquidity contract with Gilbert Dupont
ORPEA (ISIN code: FR0000184798) announces having terminated its liquidity contract concluded on 4 August 2005 with Gilbert Dupont (the “Contract”). This termination takes effect as of this day at the close of trading.
When the liquidity Contract was signed on 4 August 2005, the following resources were allocated to the liquidity account:
0 ORPEA shares
365,957.25 euros
At the termination date, the following resources were allocated to the liquidity account:
68,030 ORPEA shares
415,000 euros
Signature of a new liquidity contract with NATIXIS-ODDO BHF
Starting on 1 December 2022, ORPEA announces having concluded a new liquidity and market surveillance contract for its ordinary shares with NATIXIS-ODDO BHF, for a period of one year automatically renewable for successive 12-month periods.
This contract complies with the Autorité des Marchés Financiers (AMF) decision no. 2021-01 dated 22 June 2021 related to the establishing of liquidity contracts on shares as accepted market practice and the standard contract of the Association Française des Marchés Financiers (AMAFI).
In particular, this contract with NATIXIS-ODDO BHF aims at improving Company’s shares trading on the regulated market of Euronext Paris
The following resources have been allocated to the liquidity account:
68,030 ORPEA shares
415,000 euros
The execution of the liquidity contract may be suspended upon occurrence of the following events or conditions:
when all conditions mentioned in Article 5 of the AMF decision no. 2021-01 dated 22 June 2021 are met;
if the share is listed outside the thresholds authorized by the Company’s Shareholders’ Meeting; or
upon the Company request.
The liquidity contract may be terminated at any time and without prior notice by ORPEA, at any time by NATIXIS-ODDO BHF subject to one (1) calendar month' notice.
Suspension of the liquidity contract
ORPEA suspends the operations provided for in the liquidity contract signed with NATIXIS-ODDO BHF, at the close of the trading on 1 December 2022, until the term of the restructuring process of the Group. The Company will inform in due course when the execution of the Contract will restart.
About ORPEA
ORPEA is a leading global player, expert in the care of all types of frailty. The Group operates in 22 countries and covers three core businesses: care for the elderly (nursing homes, assisted living, home care), post-acute and rehabilitation care and mental health care (specialized clinics). It has more than 72,000 employees and welcomes more than 255,000 patients and residents each year.
